摘要
目的探讨经皮超声或CT引导射频联合瘤内无水酒精注射治疗原发性肝癌及转移性肝癌的分体活检针穿刺活检的诊断价值与安全性。方法前瞻性分析48例经皮超声或CT引导射频联合瘤内无水酒精注射治疗原发性及转移性肝癌并作了穿刺活检的病人的临床资料。结果46例病人取得病理诊断,2例未能诊断,无严重并发症。结论经皮超声或CT引导射频联合瘤内无水酒精注射治疗肝癌应用分体活检针穿刺活检安全有效,诊断率高。
Objectives To investigate the diagnostic value and safety of needle cutting biopsy for the primary and metastatic hepatic cancer during the treatment of percutaneous radiofrequency ablation and ethanol injection guided by ultrosound or CT. Methods The clinical data of 48 patients underwent the treatment of percutaneous radiofrequency ablation and ethanol injection as well as biopsy were analyzed. Results Among 48 patients,46 case(95.8%) were diagnosed by pathological examination and 2 cases (4.2%) failed to be diagnosed. There were no serious complications in all the patients. Conclusion Detachable needle cutting biopsy was safe and effective for the diagnosis of the primary and metastatic hepatic cancer during the treatment of percutaneous radiofrequency ablation and ethanol injection guided by ultrasound or CT.
出处
《中国医师杂志》
CAS
2005年第4期469-471,共3页
Journal of Chinese Physician
基金
广东省东莞市社会发展攻关基金资助项目(B2003-5)
